PharmaResearch Statistics

Total Valuation

PharmaResearch has a market cap or net worth of KRW 2.63 trillion. The enterprise value is 2.48 trillion.

Market Cap	2.63T
Enterprise Value	2.48T

Important Dates

The next estimated earnings date is Friday, February 7, 2025.

Earnings Date	Feb 7, 2025
Ex-Dividend Date	n/a

Share Statistics

PharmaResearch has 10.39 million shares outstanding. The number of shares has increased by 1.41% in one year.

Current Share Class	n/a
Shares Outstanding	10.39M
Shares Change (YoY)	+1.41%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	38.61%
Owned by Institutions (%)	23.62%
Float	5.20M

Valuation Ratios

The trailing PE ratio is 31.46 and the forward PE ratio is 21.30. PharmaResearch's PEG ratio is 0.74.

PE Ratio	31.46
Forward PE	21.30
PS Ratio	8.20
PB Ratio	5.14
P/TBV Ratio	5.50
P/FCF Ratio	27.64
P/OCF Ratio	n/a
PEG Ratio	0.74

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.88, with an EV/FCF ratio of 26.05.

EV / Earnings	27.97
EV / Sales	7.83
EV / EBITDA	18.88
EV / EBIT	20.92
EV / FCF	26.05

Financial Position

The company has a current ratio of 4.05, with a Debt / Equity ratio of 0.06.

Current Ratio	4.05
Quick Ratio	3.07
Debt / Equity	0.06
Debt / EBITDA	0.25
Debt / FCF	0.33
Interest Coverage	137.08

Financial Efficiency

Return on equity (ROE) is 17.83% and return on invested capital (ROIC) is 13.17%.

Return on Equity (ROE)	17.83%
Return on Assets (ROA)	11.98%
Return on Capital (ROIC)	13.17%
Revenue Per Employee	775.05M
Profits Per Employee	217.01M
Employee Count	409
Asset Turnover	0.54
Inventory Turnover	1.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +127.97% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+127.97%
50-Day Moving Average	222,908.00
200-Day Moving Average	162,906.00
Relative Strength Index (RSI)	63.11
Average Volume (20 Days)	144,858

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PharmaResearch had revenue of KRW 317.00 billion and earned 88.76 billion in profits. Earnings per share was 8,057.05.

Revenue	317.00B
Gross Profit	224.99B
Operating Income	112.73B
Pretax Income	112.55B
Net Income	88.76B
EBITDA	125.54B
EBIT	112.73B
Earnings Per Share (EPS)	8,057.05

Full Income Statement

Balance Sheet

The company has 216.41 billion in cash and 31.90 billion in debt, giving a net cash position of 184.51 billion or 17,758.78 per share.

Cash & Cash Equivalents	216.41B
Total Debt	31.90B
Net Cash	184.51B
Net Cash Per Share	17,758.78
Equity (Book Value)	543.03B
Book Value Per Share	49,305.53
Working Capital	254.31B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 122.27 billion and capital expenditures -26.99 billion, giving a free cash flow of 95.28 billion.

Operating Cash Flow	122.27B
Capital Expenditures	-26.99B
Free Cash Flow	95.28B
FCF Per Share	9,170.86

Full Cash Flow Statement

Margins

Gross margin is 70.97%, with operating and profit margins of 35.56% and 28.00%.

Gross Margin	70.97%
Operating Margin	35.56%
Pretax Margin	35.51%
Profit Margin	28.00%
EBITDA Margin	39.60%
EBIT Margin	35.56%
FCF Margin	30.06%

Dividends & Yields

This stock pays an annual dividend of 950.00, which amounts to a dividend yield of 0.37%.

Dividend Per Share	950.00
Dividend Yield	0.37%
Dividend Growth (YoY)	43.94%
Years of Dividend Growth	4
Payout Ratio	11.80%
Buyback Yield	-1.41%
Shareholder Yield	-1.04%
Earnings Yield	3.18%
FCF Yield	3.62%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PharmaResearch has an Altman Z-Score of 10.31.

Altman Z-Score	10.31
Piotroski F-Score	n/a